J
Jerzy Jarosz
Researcher at Polish Academy of Sciences
Publications - 17
Citations - 124
Jerzy Jarosz is an academic researcher from Polish Academy of Sciences. The author has contributed to research in topics: Cancer pain & Palliative care. The author has an hindex of 5, co-authored 17 publications receiving 99 citations.
Papers
More filters
Journal Article
Totally implantable central venous access ports
Jerzy Jarosz,Maciej Krzakowski,Kazimierz Dworzański,Irena Czech,Emilia Filipczyk-Cisarż,Iwona Głogowska,Elwira Góraj,Stanisław Góźdź,Agnieszka Jagiełło-Gruszfeld,Grzegorz Kasalik,Andrzej Komorowski,Bogusław Kosiński,Jarosław Leś,Przemysław Mańkowski,Katarzyna Matuszewska,Małgorzata Misiak,Rafał Młynarski,Łukasz Rajchert,Janusz Rolski,Maryna Rubach,Monika Sieńkowska-Magoń,Ewa Sierko,Danuta Sobańska,Bartosz Sobolewski,Jerzy Tujakowski,Marek Z. Wojtukiewicz +25 more
TL;DR: Z inicjatywy krajowego konsultanta w dziedzinie onkologii klinicznej odbylo sie spotkanie uzgodnieniowe w celu ustalenia zasad bezpiecznego stosowania portow w Polsce wszczepia sie port donaczyniowy.
Journal ArticleDOI
Superior postoperative analgesic efficacy of a continuous infusion of tramadol and dipyrone (metamizol) versus tramadol alone
TL;DR: A significantly superior analgesic efficacy of a continuous infusion of tramadol combined with dipyrone compared to an infusion of Tramadol alone or placebo is suggested.
Journal ArticleDOI
Knowledge, attitudes, and prescribing patterns of cannabis and cannabinoid-containing medicines among European healthcare workers: a systematic literature review.
TL;DR: In this paper, a comprehensive systematic literature review was performed using PubMed/MEDLINE, EMBASE, and Google Scholar databases, as well as PsychINFO to study healthcare professionals' knowledge level (HCP) and HCPs in-training regarding both medical uses and indications.
Journal ArticleDOI
Improved patient functioning after treatment of breakthrough cancer pain: an open-label study of fentanyl buccal tablet in patients with cancer pain
Andrew Davies,Ulrich R. Kleeberg,Jerzy Jarosz,Sebastiano Mercadante,Philippe Poulain,Tony O'Brien,Hélène Schneid,Hans G. Kress +7 more
TL;DR: FBT may improve patient functioning, mood, and overall satisfaction in the management of BTcP and long-term data did not indicate new safety concerns with FBT doses up to 800 μg.
Journal ArticleDOI
Pan-European, open-label dose titration study of fentanyl buccal tablet in patients with breakthrough cancer pain.
Ulrich R. Kleeberg,Andrew Davies,Jerzy Jarosz,Sebastiano Mercadante,Philippe Poulain,Tony O'Brien,H. Schneid,Hans G. Kress +7 more
TL;DR: This open‐label, randomized study compared the percentage of patients achieving an effective dose of FBT when starting titration at 100 or 200 μg.